About APCI

APCI logo

Not a member?
Join today!

(800) 532-2724

Since 1984, APCI has been the ‘united voice of independent pharmacy’

APCI began as a small buying group for a limited number of independent pharmacies in central Alabama. Since that time, the cooperative has grown to more than 1,800 members pharmacies in 26 states, and provides its members with a wide range of products and services.

Our mission is to represent the economic and professional interests of independent pharmacies by providing leadership, vision, and a collective voice for our members in the healthcare marketplace. Our goal is to level the playing field for our member pharmacies by providing innovative, targeted programs to benefit our entire membership.

7

Dec

2016

Generic News 12.7.16

This week's Generic News includes the latest on APCI's discounted generics, along with news from Centor!

7

Dec

2016

Prime Therapeutics: Processing Update for Generic Zetia® for Covered Persons of Blue Cross and Blue Shield of Alabama

Effective December 12th 2016

On December 12, 2016, generic Zetia (ezetimibe) will become available to the market. Ezetimibe will not be covered by Blue Cross and Blue Shield of Alabama until multiple manufacturers become available or the price decreases. The innovator product Zetia will continue to be covered with a tier 1 copay*.

*Please see attached PDF for more information.

7

Dec

2016

Prime Therapeutics: Processing Update for Generic Zetia® for Covered Persons of the University of Minnesota (UPlan)

Effective December 12th 2016

On December 12th, 2016, generic Zetia (ezetimibe) will become available to the market. Ezetimibe will not be covered by the UPlan until multiple manufacturers become available or the price decreases. The innovator product Zetia will continue to be covered*.

*Please see attached PDF for more information.

7

Dec

2016

Prime Therapeutics: Processing Update for Generic Zetia® for Covered Persons of Florida Blue

Effective December 12th 2016

On December 12th, 2016, generic Zetia (ezetimibe) will become available to the market. Ezetimibe will require a Prior Authorization by Florida Blue until multiple manufacturers become available or the price decreases. The innovator product Zetia will continue to be covered*.

*Please see attached PDF for more information.

7

Dec

2016

Prime Therapeutics: Processing Update for Zetia® for Covered Persons of Blue Cross and Blue Shield of Nebraska

Effective December 2016

In December 2016, Zetia (ezetimibe) will become available to the market. Ezetimibe will not be covered by Blue Cross and Blue Shield of Nebraska (BCBSNE) until multiple generic manufacturers become available or the price decreases. The innovator product, Zetia, will continue to be covered*.

*Please see attached PDF for more information.

First 576577578579 Last